245 related articles for article (PubMed ID: 23664530)
41. Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording.
De Vita S; Isola M; Baldini C; Goules AV; Chatzis LG; Quartuccio L; Zabotti A; Giovannini I; Donati V; Ferro F; Rizzo MT; Manfrè V; Pegolo E; Voulgarelis M; Zaja F; Fanin R; Masaoutis C; Rontogianni D; Fotiadis DI; Ponzoni M; Tzioufas AG
Rheumatology (Oxford); 2023 Apr; 62(4):1586-1593. PubMed ID: 36063040
[TBL] [Abstract][Full Text] [Related]
42. Primary Sjögren's syndrome and its lymphoid malignancy: a report of four cases.
Dong Y; Zhao Y; Zeng X; Sun D
Chin Med J (Engl); 1998 Mar; 111(3):218-9. PubMed ID: 10374419
[TBL] [Abstract][Full Text] [Related]
43. Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS.
Zufferey P; Meyer OC; Grossin M; Kahn MF
Scand J Rheumatol; 1995; 24(6):342-5. PubMed ID: 8610217
[TBL] [Abstract][Full Text] [Related]
44. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
[TBL] [Abstract][Full Text] [Related]
45. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
46. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
Ter Borg EJ; Kelder JC
Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
[TBL] [Abstract][Full Text] [Related]
47. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
48. Outcome measures for primary Sjögren's syndrome: a comprehensive review.
Seror R; Theander E; Bootsma H; Bowman SJ; Tzioufas A; Gottenberg JE; Ramos-Casals M; Dörner T; Ravaud P; Mariette X; Vitali C
J Autoimmun; 2014 Jun; 51():51-6. PubMed ID: 24411404
[TBL] [Abstract][Full Text] [Related]
49. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
[TBL] [Abstract][Full Text] [Related]
50. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
51. Malignant lymphoma in primary Sjogren's syndrome.
Voulgarelis M; Moutsopoulos HM
Isr Med Assoc J; 2001 Oct; 3(10):761-6. PubMed ID: 11692552
[TBL] [Abstract][Full Text] [Related]
52. [Lung involvement of primary Sjögren's syndrome].
Yan SM; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jul; 31(7):513-6. PubMed ID: 19035231
[TBL] [Abstract][Full Text] [Related]
53. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: initial and follow-up imaging features.
Tonami H; Matoba M; Yokota H; Higashi K; Yamamoto I; Sugai S
AJR Am J Roentgenol; 2002 Aug; 179(2):485-9. PubMed ID: 12130459
[TBL] [Abstract][Full Text] [Related]
54. Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome.
Jonsson MV; Theander E; Jonsson R
Presse Med; 2012 Sep; 41(9 Pt 2):e511-6. PubMed ID: 22867948
[TBL] [Abstract][Full Text] [Related]
55. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
[TBL] [Abstract][Full Text] [Related]
56. [Evolutive forms of primary Sjögren's syndrome].
Fauchais AL; Gondran G; Martel C; Vidal E
Rev Prat; 2012 Feb; 62(2):229-31. PubMed ID: 22408871
[TBL] [Abstract][Full Text] [Related]
57. [Sjögren's syndrome associated with reticulum cell sarcoma].
Ishino T; Nakaguchi N; Fujita S; Yamamoto H; Otsuka K
Naika; 1972; 29(1):192-6. PubMed ID: 4551770
[No Abstract] [Full Text] [Related]
58. [Lymphoma of the parotid gland in Sjögren syndrome].
González Hernández T; Balsa Criado A; García Girón C; Crespo Echeverría M
Med Clin (Barc); 1988 Mar; 90(12):515-6. PubMed ID: 3393036
[No Abstract] [Full Text] [Related]
59. A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.
Abrol E; González-Pulido C; Praena-Fernández JM; Isenberg DA
Clin Med (Lond); 2014 Apr; 14(2):157-64. PubMed ID: 24715127
[TBL] [Abstract][Full Text] [Related]
60. Predicting progression to lymphoma in Sjögren's syndrome patients.
Giannouli S; Voulgarelis M
Expert Rev Clin Immunol; 2014 Apr; 10(4):501-12. PubMed ID: 24451006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
